Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 8, 2002Clinical Infectious Diseases

Has Antifungal Susceptibility Testing Come of Age?

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJohn RexMPMichael A. Pfaller

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rex et al. (2002) studied this question.

synapsesocial.com/papers/6a7696084ea07eb233cff4d0https://doi.org/10.1086/342384
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation of In Vitro Fluconazole Susceptibility with Clinical Outcome for Severely Ill Patients with Oropharyngeal Candidiasis1998 · 27 citations
  2. 2Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational Trial2000 · 216 citations
  3. 3Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection2000 · 170 citations
  4. 4The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults1997 · 1,223 citations
  5. 5Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with<i>Candida</i>Fungemia1998 · 219 citations